Dorzolamide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00869 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 49 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary hereditary glaucoma | KG + DL |
| 2 | hypotrichosis simplex of the scalp | KG + DL |
| 3 | congenital hypotrichosis milia | KG + DL |
| 4 | alopecia | KG + DL |
| 5 | diffuse alopecia areata | KG + DL |
| 6 | glaucoma 1, open angle | KG + DL |
| 7 | open angle glaucoma | KG + DL |
| 8 | congestive heart failure | KG + DL |
| 9 | acute pulmonary heart disease | KG + DL |
| 10 | respiratory failure | KG + DL |
| 11 | Axenfeld anomaly | KG + DL |
| 12 | familial periodic paralysis | KG + DL |
| 13 | exercise-induced malignant hyperthermia | KG + DL |
| 14 | hypotrichosis of eyelid | KG + DL |
| 15 | closed-angle glaucoma | KG + DL |
| 16 | arterial thoracic outlet syndrome | KG + DL |
| 17 | venous thoracic outlet syndrome | KG + DL |
| 18 | visceral calciphylaxis | KG + DL |
| 19 | pseudopelade of Brocq | KG + DL |
| 20 | small intestine cancer | KG + DL |
| 21 | potassium deficiency disease | KG + DL |
| 22 | small intestine adenocarcinoma | KG + DL |
| 23 | angiodysplasia of stomach | KG + DL |
| 24 | ileal neoplasm | KG + DL |
| 25 | blue toe syndrome | KG + DL |
| 26 | neurogenic thoracic outlet syndrome | KG + DL |
| 27 | benign neoplasm of small intestine | KG + DL |
| 28 | hemangioendothelioma | KG + DL |
| 29 | atheroembolism of kidney | KG + DL |
| 30 | lymphangiectasis | KG + DL |
| 31 | vascular disease | KG + DL |
| 32 | hypokalemic periodic paralysis | KG + DL |
| 33 | jejunal neoplasm | KG + DL |
| 34 | idiopathic spontaneous coronary artery dissection | KG + DL |
| 35 | chronic kidney disease | KG + DL |
| 36 | thyrotoxic periodic paralysis, susceptibility to | KG + DL |
| 37 | end stage renal failure | KG + DL |
| 38 | androgenetic alopecia | KG + DL |
| 39 | arterial dissection-lentiginosis syndrome | KG + DL |
| 40 | angle-closure glaucoma | KG + DL |
| 41 | genetic alopecia | KG + DL |
| 42 | jejunal adenocarcinoma (disease) | KG + DL |
| 43 | chronic pulmonary heart disease | KG + DL |
| 44 | congenital glaucoma | KG + DL |
| 45 | thyrotoxic periodic paralysis | KG + DL |
| 46 | renal tubular acidosis | KG + DL |
| 47 | adrenal gland pheochromocytoma | KG + DL |
| 48 | extra-adrenal sympathetic paraganglioma | KG + DL |
| 49 | duodenum cancer | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.